Haemonetics Corp

HAE

Company Profile

  • Business description

    Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

  • Contact

    125 Summer Street
    BostonMA02110
    USA

    T: +1 781 848-7100

    E: [email protected]

    https://www.haemonetics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 March 2025

    Employees

    3,657

Stocks News & Analysis

stocks

ASX shares plunge but remain undervalued

Shares drop 17% after guidance is revised but we still see value.
stocks

Ask the analyst: Why have markets shunned APA Group?

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.
stocks

The 10 best US dividend stocks

These undervalued stocks with reliable dividends are worth considering.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,543.7034.10-0.40%
CAC 407,431.0459.24-0.79%
DAX 4020,214.79102.31-0.50%
Dow JONES (US)41,938.45696.75-1.63%
FTSE 1008,248.4971.20-0.86%
HKSE19,064.29176.60-0.92%
NASDAQ19,161.63317.25-1.63%
Nikkei 22539,190.40414.69-1.05%
NZX 50 Index12,895.9847.76-0.37%
S&P 5005,827.0491.21-1.54%
S&P/ASX 2008,294.1035.10-0.42%
SSE Composite Index3,168.5242.87-1.33%

Market Movers